ReEmerge, Inc. Exits Stealth with Oversubscribed $37M Series A to Challenge the Limitations of Chronic Cognitive Impairment Caused by Brain Injuries

Summary

ReEmerge, Inc. exited stealth mode with an oversubscribed $37M Series A funding round to develop Cognitive Network Restoration Therapy (CNRT) for treating chronic cognitive impairment from brain injuries. The technology targets brain networks involved in executive function to restore cognitive function years after initial injury.